Keywords: بازدارنده بازرسی; Crystal-induced arthritis; Gout; CPPD; Pembrolizumab; Checkpoint inhibitor;
مقالات ISI بازدارنده بازرسی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بازدارنده بازرسی; Immunotherapy; Organ transplant; Allograft; Immune checkpoint; Checkpoint inhibitor;
Keywords: بازدارنده بازرسی; Localized; Muscle-invasive; Non-muscle-invasive; Bladder cancer; Checkpoint inhibitor; PD-1; PD-L1; CTLA-4; Treatment; Therapy;
Keywords: بازدارنده بازرسی; cardio-oncology; checkpoint inhibitor; ipilimumab; myocarditis; nivolumab; pembrolizumab; anti-CTLA4; anti-cytotoxic T-lymphocyte-associated protein 4; anti-PD1; anti-programmed cell death protein 1; anti-PDL1; anti-programmed death-ligand 1; AUC; area un
Keywords: بازدارنده بازرسی; Checkpoint inhibitor; Hyperprogression; Pseudoprogression; Tumor growth rate;
Keywords: بازدارنده بازرسی; oncology; cancer; oncologic emergencies; checkpoint inhibitor; toxicity; toxicities; chemotherapy; immunotherapy; pneumonitis; colitis; thyroiditis; hypophysitis; dermatitis; immune checkpoint inhibitor; immunotherapy-related adverse events; irAEs; ICPI;
Keywords: بازدارنده بازرسی; ICI; immune checkpoint inhibition; irAE; immune related adverse event; TME; tumor microenvironment; Melanoma; Biomarker; Checkpoint inhibitor; PD-1; CTLA-4;
Keywords: بازدارنده بازرسی; Breast cancer; Checkpoint inhibitor; Immunotherapy;
Keywords: بازدارنده بازرسی; Prostate cancer; Tumor vaccine; Immunotherapy; PARP inhibitor; Checkpoint inhibitor;
Keywords: بازدارنده بازرسی; Melanoma; Adverse event; Checkpoint inhibitor; White blood cell count; Blood cell parameters; Relative lymphocyte count;
Keywords: بازدارنده بازرسی; adenocarcinoma; checkpoint inhibitor; immunotherapy; lung cancer; lymphocytes;
Keywords: بازدارنده بازرسی; Lymphatic vessels; Photodynamic therapy; Lenalidomide; Anti-PD-L1 antibody; checkpoint inhibitor;
Keywords: بازدارنده بازرسی; immunotherapy; checkpoint inhibitor; eye; toxicity; interprofessional collaboration; management;
Keywords: بازدارنده بازرسی; Angiogenesis; Gastric cancer; Esophageal cancer; Immunotherapy; Checkpoint inhibitor;
Keywords: بازدارنده بازرسی; Cervical cancer; Immunotherapy; Human papillomavirus; Therapeutic vaccine; Checkpoint inhibitor; Chimeric T cell receptor antigen;
Keywords: بازدارنده بازرسی; Ipilimumab; Tremelimumab; Nivolumab; Immunotherapy; Checkpoint inhibitor; Anti-PD-1; Anti-PD-L1; Anti-CTLA4;
Percutaneous ablative cryoimmunotherapy for micrometastaic abscopal effect: No complications
Keywords: بازدارنده بازرسی; Abscopal effect; Cancer stem cell; Checkpoint inhibitor; Cryoimmunotherapy; Neoantigen; Renal cell carcinoma; Tumor microenvironment; Tumor vaccine; PD-1; programmed death 1; TIL; tumor-infiltrating lymphocytes; ECM; extracellular matrix; TAA; tumor-assoc
Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients
Keywords: بازدارنده بازرسی; Melanoma; Checkpoint inhibitor; Ipilimumab; Nivolumab; Switching;
Neoadjuvant therapy for localized and locally advanced renal cell carcinoma
Keywords: بازدارنده بازرسی; Carcinoma, Renal cell; Checkpoint inhibitor; Partial nephrectomy; Radical nephrectomy; Targeted therapy, Molecular;
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma
Keywords: بازدارنده بازرسی; Mesothelioma; Immunotherapy; Programmed death ligand 1; Nivolumab; Checkpoint inhibitor;
Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer
Keywords: بازدارنده بازرسی; Checkpoint inhibitor; Immunotherapy; Lung cancer; NLR; PD-1 inhibitor;
Sequential CT Findings in Patients With Non-small-cell Lung Cancer Receiving Nivolumab
Keywords: بازدارنده بازرسی; Checkpoint inhibitor; Imaging; Immunotherapy; Response;
Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study
Keywords: بازدارنده بازرسی; Checkpoint inhibitor; Immunohistochemical analysis; Interstitial pneumonia; Programmed cell death protein 1; PD-L1;
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer
Keywords: بازدارنده بازرسی; Atezolizumab; PD-L1; Checkpoint inhibitor; Non-small cell lung cancer; Cancer immunotherapy;
Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505)
Keywords: بازدارنده بازرسی; Abscopal effect; Checkpoint inhibitor; Coprimary end points; Immunotherapy; Programmed death 1 (PD-1);
Immunothérapie dans les cancers de la prostate
Keywords: بازدارنده بازرسی; Vaccins; Checkpoint inhibiteurs; Urologie; Vaccines; Checkpoint inhibitor; Urology;
ReviewThe role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma
Keywords: بازدارنده بازرسی; CTLA-4; PD-1; Osteosarcoma; Checkpoint inhibitor; Immunotherapy;
Cytotoxic T-Lymphocyte Antigen-4 Blockade in Melanoma
Keywords: بازدارنده بازرسی; autoimmunity; checkpoint inhibitor; CTLA4; ipilimumab;
Synthesis and structure–activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases
Keywords: بازدارنده بازرسی; Pyrrolocarbazole; G2/M checkpoint abrogation; Wee1 kinase inhibitor; Chk1 kinase inhibitor; Checkpoint inhibitor
Structure-activity relationships for 2-anilino-6-phenylpyrido[2,3-d]pyrimidin-7(8H)-ones as inhibitors of the cellular checkpoint kinase Wee1
Keywords: بازدارنده بازرسی; Pyridopyrimidine; Checkpoint inhibitor; Wee1 kinase inhibitor;